Citigroup upgraded its rating on shares of Bristol-Myers Squibb (BMY) Wednesday morning to "Buy" from "Neutral."
Bristol-Myers Squibb gapped up Wednesday and climbed for the majority of the morning. Shares ended the day higher by 2.34 at $46.40 on above average volume. The stock has been gaining ground for the last 2 weeks and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.